SCHEMBL4017550

SCHEMBL4017550

CC(C)Sc1ccc(OBOc2ccc(SC(C)C)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 2/20 0.36
XDH P47989 1/20 0.32
ACACB O00763 1/20 0.32
ACACA Q13085 1/20 0.32
LMNA P02545 2/20 0.31
MEN1 O00255 1/20 0.31
XBP1 P17861 1/20 0.31
KMT2A Q03164 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
ABCB11 O95342 1/20 0.31
ALDH1A1 P00352 1/20 0.31
EGFR P00533 1/20 0.31
ESR1 P03372 1/20 0.31
TP53 P04637 1/20 0.31
CYP1A2 P05177 1/20 0.31
FYN P06241 1/20 0.31
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
CYP3A4 P08684 1/20 0.31
HTR1A P08908 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17968401 0.79 AR (0.39) ARXDHACACBACACALMNA
SCHEMBL4192430 0.77 CA1 (0.52) ARLMNAMEN1KMT2ANPSR1
SCHEMBL5852771 0.76 ALDH1A3 (0.47) ARLMNAKMT2AALDH1A1TP53
SCHEMBL911093 0.75 CYP1A1 (0.47) ALDH1A1CYP1A2SLC6A4KCNH2
SCHEMBL21972707 0.71 LMNA (0.36) ARACACBACACALMNAMEN1
SCHEMBL3593298 0.71 AR (0.34) ARXDHACACBACACALMNA
SCHEMBL17374513 0.71 PDE2A (0.45) ARALDH1A1TSHRSLC6A2SLC6A4
SCHEMBL8588330 0.71 AR (0.38) ARXDHLMNAMEN1XBP1
SCHEMBL21186075 0.71 XDH (0.44) ARXDHLMNAMEN1XBP1
SCHEMBL1091051 0.70 KMT2A (0.40) MEN1XBP1KMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009133970-A1 CRYSTALLINE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-11-05 WO disclosed
EP-2074117-A2 HETEROMONOCYCLIC COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2009-07-01 EP disclosed
WO-2008062905-A2 HETEROMONOCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-05-29 WO disclosed